Results 131 to 140 of about 1,594,352 (310)
Immunomodulation for type 1 diabetes mellitus
Type 1 diabetes (T1D) is characterised by immune-mediated pancreatic islet beta-cell destruction. The initial immune response engenders secondary and tertiary responses which collectively result in impairment of beta-cell function, progressive destruction of beta-cells and consequent development of T1D. The process is insidious and may evolve over many
openaire +3 more sources
The study reveals that glutaminolysis in macrophages is inhibited under type 2 diabetes mellitus (T2DM) conditions, which impedes fracture healing by reducing bone morphogenetic protein 2 (BMP2) production through increased cytosine methylation on the promoter.
Jing Wang+12 more
wiley +1 more source
Lingwen Ying,1,* Yong Zhang,2,* Jun Yin,1,* Yufei Wang,1 Wei Lu,1 Wei Zhu,1 Yuqian Bao,1 Jian Zhou1 1Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital; Shanghai Clinical Center for ...
Ying L+7 more
doaj
Exploring Biomarker Relationships in Both Type 1 and Type 2 Diabetes Mellitus Through a Bayesian Network Analysis Approach [PDF]
Understanding the complex relationships of biomarkers in diabetes is pivotal for advancing treatment strategies, a pressing need in diabetes research. This study applies Bayesian network structure learning to analyze the Shanghai Type 1 and Type 2 diabetes mellitus datasets, revealing complex relationships among key diabetes-related biomarkers.
arxiv
GAMBARAN POLA MAKAN PASIEN DIABETES MELLITUS TIPE 2 [PDF]
Background: Diabetes Mellitus (DM) is a disease caused by a decrease in insulin production due to lack of functioning of the pancreas, resulting in an increase in blood sugar levels in the body.
Anggraini, Sindi Meita
core
Dehydroepiandrosterone in the type 1 diabetes mellitus
Dehydroepiandrosterone (DHEA) is believed to exert, besides others, positive effects on the insulin resistance or its secretion and glucose metabolism. There are several reports dealing with the DHEA levels and its effects in the type 2 diabetes mellitus, but less information is available on the type 1 diabetic subjects. Recently, a report dealing with
Hana Hruskovicova+3 more
openaire +3 more sources
Baicalin alleviates E. coli‐induced intestinal inflammation through dual mechanisms: direct inhibition of the TLR4/IRF/STAT signaling pathway to modulate macrophage polarization and antigen presentation, thereby regulating Th17/Treg cell differentiation; and microbiota‐mediated indirect effects via increasing Lactobacillus amylovorus abundance and ...
Shunfen Zhang+10 more
wiley +1 more source
In this study, Merkoçi and his research group present a polymer‐based synthesis to enhance the stability of Prussian blue (PB) nanoparticles. The resulting PB‐infused catalytic hetero‐interface architecture (PB‐CHIA) achieves complete two‐dimensional (2D) and three‐dimensional (3D) substrate coverage (glassy carbon and laser‐induced graphene electrodes)
Sinan Uzunçar+3 more
wiley +1 more source
Integrating Bayesian Approaches and Expert Knowledge for Forecasting Continuous Glucose Monitoring Values in Type 2 Diabetes Mellitus [PDF]
Precise and timely forecasting of blood glucose levels is essential for effective diabetes management. While extensive research has been conducted on Type 1 diabetes mellitus, Type 2 diabetes mellitus (T2DM) presents unique challenges due to its heterogeneity, underscoring the need for specialized blood glucose forecasting systems.
arxiv
Explainable Deep Multilevel Attention Learning for Predicting Protein Carbonylation Sites
Selective carbonylation sites (SCANS) are conceptualized, designed, evaluated, and released. SCANS captures segment‐level, protein‐level, and residue embeddings features. It utilizes elaborate loss function to penalize cross‐predictions at the residue level.
Jian Zhang+6 more
wiley +1 more source